Attached files
file | filename |
---|---|
EX-31.3 - EX-31.3 - Altimmune, Inc. | d578268dex313.htm |
10-K/A - FORM 10-K/A - Altimmune, Inc. | d578268d10ka.htm |
Exhibit 31.4
Certification of Principal Executive Officer
Pursuant to SEC Rule 13a-14(a)/15d-14(a)
I, Elizabeth A. Czerepak, certify that:
1. | I have reviewed this Amendment No. 1 to the annual report on Form 10-K of Altimmune, Inc. for the year ended December 31, 2017; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Dated: April 30, 2018 | /s/ Elizabeth A. Czerepak | |
Name: Elizabeth A. Czerepak | ||
Title: Chief Financial Officer, Executive Vice President of Corporate Development and Secretary (principal financial officer) |